Evidence map›Paper›PMID 28442534›Full record

ArticleThe Journal of cell biology2017

Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids.

Pamela Riemer, Mattias Rydenfelt, Matthias Marks, Karen van Eunen, Kathrin Thedieck, Bernhard G Herrmann, Nils Blüthgen, Christine Sers, Markus Morkel

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of cell biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  9. BRAFOncogene · 2020
    Article
  10. PI3K in stemness regulation: from development to cancer.Biochemical Society transactions · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Pamela RiemerLaboratory of Molecular Tumor Pathology, Institute of Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0003-3231-7056
Mattias RydenfeltIntegrative Research Institute Life Sciences, Humboldt University Berlin, 10099 Berlin, Germany.
Matthias MarksDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Karen van EunenDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University Medical Center Groningen, 9713 GZ Groningen, Netherlands.ORCID 0000-0001-5603-1883
Kathrin ThedieckDepartment of Pediatrics, Center for Liver, Digestive and Metabolic Diseases, University Medical Center Groningen, 9713 GZ Groningen, Netherlands.
Bernhard G HerrmannDepartment of Developmental Genetics, Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany.
Nils BlüthgenLaboratory of Molecular Tumor Pathology, Institute of Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.ORCID 0000-0002-0171-7447
Christine SersLaboratory of Molecular Tumor Pathology, Institute of Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany.
Markus MorkelLaboratory of Molecular Tumor Pathology, Institute of Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany markus.morkel@charite.de.ORCID 0000-0002-2553-9999
German Cancer Research Center · DEHumboldt-Universität zu Berlin · DEMax Planck Institute for Molecular Genetics · DEUniversity Medical Center Groningen · NLCharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is driven by cooperating oncogenic mutations. In this study, we use organotypic cultures derived from transgenic mice inducibly expressing oncogenic β-catenin and/or PIK3CA

Indexed as

Signal TransductionAdaptor Proteins, Signal TransducingAnimalsApoptosisbeta CateninCell AdhesionCell Cycle ProteinsCell MovementCell ProliferationCells, CulturedCell SurvivalCell Transformation, NeoplasticClass I Phosphatidylinositol 3-KinasesGene Expression ProfilingGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseAdaptor Proteins, Signal Transducingbeta CateninCell Cycle ProteinsClass I Phosphatidylinositol 3-KinasesCTNNB1 protein, mouseEIF4EBP1 protein, humanPhosphatidylinositol 3-KinasesPhosphoproteinsPIK3CA protein, humanProto-Oncogene Proteins c-akt

Identifiers

PMID28442534
PMCPMC5461020
OpenAlexW2608721304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.